BR112013008511A2 - tipagem com base em determinantes moleculares de alelos de kir e de ligantes de kir - Google Patents

tipagem com base em determinantes moleculares de alelos de kir e de ligantes de kir

Info

Publication number
BR112013008511A2
BR112013008511A2 BR112013008511A BR112013008511A BR112013008511A2 BR 112013008511 A2 BR112013008511 A2 BR 112013008511A2 BR 112013008511 A BR112013008511 A BR 112013008511A BR 112013008511 A BR112013008511 A BR 112013008511A BR 112013008511 A2 BR112013008511 A2 BR 112013008511A2
Authority
BR
Brazil
Prior art keywords
kir
typing
ligands
alleles
molecular determinants
Prior art date
Application number
BR112013008511A
Other languages
English (en)
Inventor
Bari Rafijul
Leung Wing
Original Assignee
St Jude Childrens Res Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Jude Childrens Res Hospital filed Critical St Jude Childrens Res Hospital
Publication of BR112013008511A2 publication Critical patent/BR112013008511A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

tipagem com base em determinantes moleculares de alelos de kir e de ligantes de kir. a presente invenção diz respeito a um ensaio com base em determinantes moleculares para realizar a tipagem de alelos funcionais e a tipagem de ligantes de receptores semelhantes à imunoglobulina de células natural killer (kir) e para a tipagem de ligantes. especificamente, a presente invenção provê métodos, composições e kits para um ensaio de polimorfismo de nucleotídeo único (snp) para classificar o tipo de vários grupos de alelos de kir2dl1 e de ligantes de kir com propriedades funcionais distintas com base em polimorfismo na posição 245 em kir2dl1, posição 77 em hla-c e na posição 83 em hla-b e hla-a. os ensaios são adequados para uso em predizer a atividade de células nk na saúde, doença e processos de transplante.
BR112013008511A 2010-10-06 2011-10-05 tipagem com base em determinantes moleculares de alelos de kir e de ligantes de kir BR112013008511A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39047310P 2010-10-06 2010-10-06
PCT/US2011/054906 WO2012047985A1 (en) 2010-10-06 2011-10-05 Molecular determinant-based typing of kir alleles and kir-ligands

Publications (1)

Publication Number Publication Date
BR112013008511A2 true BR112013008511A2 (pt) 2017-07-25

Family

ID=45928116

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013008511A BR112013008511A2 (pt) 2010-10-06 2011-10-05 tipagem com base em determinantes moleculares de alelos de kir e de ligantes de kir

Country Status (5)

Country Link
US (1) US20130267613A1 (pt)
EP (1) EP2625188A4 (pt)
CN (1) CN103209988B (pt)
BR (1) BR112013008511A2 (pt)
WO (1) WO2012047985A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104032025B (zh) * 2014-06-25 2016-04-27 上海荻硕贝肯生物科技有限公司 用于kir基因快速分型的引物、试剂盒及方法
PT3385395T (pt) 2015-08-17 2020-05-06 Kura Oncology Inc Métodos de tratamento de doentes com cancro usando inibidores da farnesiltransferase
CN108624665A (zh) * 2018-05-18 2018-10-09 韩瑜 一种kir及配体基因分型实验方法
CN111088349B (zh) * 2020-02-14 2023-04-28 深圳市宝安区妇幼保健院 Kir3dl1基因分型引物组及其应用
CN112442525B (zh) * 2020-11-20 2022-11-04 江苏伟禾生物科技有限公司 用于检测人类自然杀伤细胞免疫球蛋白样受体kir基因分型的试剂盒

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5874212A (en) * 1993-05-13 1999-02-23 Thomas Jefferson University Detection of single base mutations and other variations in double stranded DNA by conformation-sensitive gel electrophoresis
US6790616B1 (en) * 1998-11-26 2004-09-14 Shionogi & Co., Ltd. Method for typing of HLA class I alleles
SI1639013T1 (sl) * 2003-07-02 2013-01-31 Innate Pharma Pan-kir2dl nk-receptorska protitelesca in njihova uporaba pri diagnosticiranju in terapiji
GB0322037D0 (en) * 2003-09-19 2003-10-22 Animal Health Inst Method and polynucleotides therefor
EP1685149A4 (en) * 2003-10-22 2007-03-28 Pel Freez Clinical Systems Inc PRIMER, METHOD AND KITS FOR DETECTING ALL KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTOR
US7374927B2 (en) * 2004-05-03 2008-05-20 Affymetrix, Inc. Methods of analysis of degraded nucleic acid samples
WO2006003179A2 (en) * 2004-07-01 2006-01-12 Novo Nordisk A/S Antibodies binding to receptors kir2dl1, -2, 3 but not kir2ds4 and their therapeutic use
WO2007041067A2 (en) * 2005-09-29 2007-04-12 Children's Hospital & Research Center At Oakland Methods and compositions for kir genotyping
WO2008121894A2 (en) * 2007-03-30 2008-10-09 Escape Therapeutics, Inc. Endogenous expression of hla-g and/or hla-e by mesenchymal cells
GB0724131D0 (en) * 2007-12-11 2008-01-23 Uutech Ltd Use of KIR genes for predicting response to therapy

Also Published As

Publication number Publication date
CN103209988B (zh) 2016-11-09
WO2012047985A1 (en) 2012-04-12
CN103209988A (zh) 2013-07-17
EP2625188A1 (en) 2013-08-14
US20130267613A1 (en) 2013-10-10
EP2625188A4 (en) 2014-05-07

Similar Documents

Publication Publication Date Title
CY1123287T1 (el) Αναλυση γονιδιωματικων κλασματων με χρηση των αριθμων πολυμορφισμων
Cerhan et al. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma
Chang et al. Association of HLA‐B* 1502 allele with carbamazepine‐induced toxic epidermal necrolysis and Stevens–Johnson syndrome in the multi‐ethnic Malaysian population
Blankenberg et al. Dissemination of scientific software with Galaxy ToolShed
BR112013008511A2 (pt) tipagem com base em determinantes moleculares de alelos de kir e de ligantes de kir
Gendzekhadze et al. High KIR diversity in Amerindians is maintained using few gene-content haplotypes
ATE509123T1 (de) Hochauflösende hochdurchsatz-hla-genotypisierung mittels klonaler sequenzierung
WO2014116729A3 (en) Haplotying of hla loci with ultra-deep shotgun sequencing
Kawashima et al. Evolutionary analysis of classical HLA class I and II genes suggests that recent positive selection acted on DPB1* 04∶ 01 in Japanese population
Lank et al. Ultra-high resolution HLA genotyping and allele discovery by highly multiplexed cDNA amplicon pyrosequencing
Rajasuriar et al. The role of SNPs in the α-chain of the IL-7R gene in CD4+ T-cell recovery in HIV-infected African patients receiving suppressive cART
Bettens et al. High-allelic variability in HLA-C mRNA expression: association with HLA-extended haplotypes
NZ612799A (en) Improved method and kit for determining severity and progression of periodontal disease
Vazirabad et al. Direct HLA genetic comparisons identify highly matched unrelated donor-recipient pairs with improved transplantation outcome
Mack et al. High resolution HLA analysis reveals independent class I haplotypes and amino-acid motifs protective for multiple sclerosis
Rêgo et al. Population genetic studies of mitochondrial pseudo-control region in the endangered Araripe Manakin (Antilophia bokermanni)
Nunes et al. Population variation of HLA genes in rural communities in Brazil, the Quilombos from the Vale do Ribeira, São Paulo–Brazil
Lau et al. Characterisation of major histocompatibility complex class I genes in Japanese Ranidae frogs
Qi et al. Utility of next‐generation sequencing methods to identify the novel HLA alleles in potential stem cell donors from Chinese Marrow Donor Program
McKinney et al. Development and validation of a sample sparing strategy for HLA typing utilizing next generation sequencing
Norman et al. Very long haplotype tracts characterized at high resolution from HLA homozygous cell lines
Astuti et al. The DNA sequence performance of COI gene in white cockatoos (Cacatua, Psittaciformes)
Ibarra et al. Using STR, MiniSTR and SNP markers to solve complex cases of kinship analysis
Jinam Human leukocyte antigen (HLA) region in human population studies
Hsu et al. Development of 24 new microsatellite markers in the Crested Serpent Eagle (Spilornis cheela hoya)

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]